About the Preventive and Public Health Research initiative
The Preventive and Public Health Research initiative will provide $545.1 million over 10 years between 2024–25 and 2033–34 towards research that tests innovative approaches to preventive and public health issues. It will fund targeted research into new ways to address risk factors for chronic and complex diseases in Australia.
This initiative will support projects that:
- identify and prioritise research that will most benefit patients and their families (Consumer Led Research, $100 million over 10 years)
- assess the effectiveness of drugs and interventions, in order to improve the evidence base on the cost-effectiveness and comparative effectiveness of health care and strategies (Health Technology Assessment, $100 million over 10 years)
- support the development and implementation of strategies and approaches for improving the health of pregnant women, mothers and young children, particularly those focused on vulnerable populations; and strategies and approaches for early detection and early intervention in at-risk individuals (Maternal Health and Early Childhood, $75 million over 10 years)
- support the development and implementation of strategies and approaches for addressing modifiable risk factors at key life stages – childhood, adolescence, mid-life, and amongst older people (Healthy Lifestyles, $75 million over 10 years).
In addition, the initiative will support ongoing investments in:
- chronic respiratory conditions
- the Targeted Translation Research Accelerator.
Why it is important
This initiative is important because it aims to:
- help research findings and evidence-based practice become part of routine practice
- improve health outcomes of people with complex and chronic conditions, particularly in disadvantaged regional and rural communities
- integrate research outcomes into community-based health services and support education programs.
Objectives
The objective of this initiative is to support research into new ways to address risk factors for chronic and complex diseases in Australia.
Meeting our objectives
We will monitor the initiative in accordance with the principles and approach detailed in the MRFF Monitoring, evaluation and learning strategy.
Who we work with
The Medical Research Future Fund (MRFF) funds the initiative.
The Targeted Translation Research Accelerator Plan Expert Advisory Panel advised on diabetes and cardiovascular disease investments under this initiative.
The Health Technology (HTA) Chairs Committee advises on investments under the HTA stream of this initiative.
Our Health and Medical Research Office oversees this and other MRFF initiatives.
The National Health and Medical Research Council (NHMRC) and the Department of Industry, Science and Resources administer this initiative.
Apply for funding
View the MRFF grants calendar to see which grants are open, when applications close and when we expect to award funding.
Register with GrantConnect to receive notifications about future funding opportunities under this initiative.
Grants awarded
See a list of all MRFF grant recipients.
Contact
For more information, contact us.
Medical Research Future Fund (MRFF) contact
National Health and Medical Research Council (NHMRC)
